HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GM-CSF in the treatment of Felty syndrome.

Abstract
Many therapeutic agents have been tried with variable success in the treatment of Felty neutropenia, but the reports are anecdotal. We now describe the second trial of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF), in a splenectomized, infected patient with Felty syndrome.
AuthorsG Joseph, D H Neustadt, J Hamm, M Kellihan, T Hadley
JournalAmerican journal of hematology (Am J Hematol) Vol. 37 Issue 1 Pg. 55-6 (May 1991) ISSN: 0361-8609 [Print] United States
PMID2024642 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Recombinant Proteins
  • Granulocyte-Macrophage Colony-Stimulating Factor
Topics
  • Felty Syndrome (drug therapy)
  • Granulocyte-Macrophage Colony-Stimulating Factor (therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Neutropenia (drug therapy)
  • Recombinant Proteins (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: